SIRPA and neoplasm: Then the three as‐obtained nanovesicles were mixed to form HMNVs, which could not only block the CD47/SIRPα signaling pathway but also promote M2‐to‐M1 reprogramming within tumor tissues, eventually leading to a remarkable effect of tumor immunotherapy.